Lupin has reported results for the fourth quarter and year ended March 31, 2019. 

The company has reported a rise of 85.59% in its net profit at Rs 542.78 crore for the quarter ended March 31, 2019 as compared to Rs 292.46 crore for the same quarter in the previous year. Total income of the company increased by 19.33% at Rs 3,019.97 crore for quarter under review as compared to Rs 2,530.83 crore for the quarter ended March 31, 2018.

On consolidated basis, the company has reported a net profit at Rs 296.37 crore for the quarter ended March 31, 2019  against net loss of Rs 777.60 crore for the corresponding quarter in the FY18. Total consolidated income of the company rose 7.52% at Rs 4,492.82 crore for quarter under review as compared to Rs 4,178.75 crore for the same quarter ended previous year.

For the year ended March 31, 2019, the company has posted a rise of 14.44% in its net profit at Rs 1,538.83 crore as compared to Rs 1,344.66 crore for the previous year. Total income of company increased 13.98% at Rs 11,647.66 crore for year under review as compared to Rs 10,219.30 crore for year ended March 31, 2018.

For the year ended March 31, 2019, on the consolidated basis, the company has posted 2-fold jump in its net profit at Rs 615.48 crore as compared to Rs 258.35 crore for the previous year. Total income of company increased by 7.07% at Rs 17,082.20 crore for year under review as compared to Rs 15,954.50 crore for year ended March 31, 2018.

Lupin Share Price

2160.10 -21.35 (-0.98%)
12-Jan-2026 11:38 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.00
Dr. Reddys Lab 1200.85
Cipla 1458.45
Zydus Lifesciences 887.20
Lupin 2160.10
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×